First in-human study update – webcast presentation

Jun 24, 2020
Posted in: Investor updates, Press & Media

Home » First in-human study update – webcast presentation

First in-human study update – webcast presentation

Jun 24, 2020
Posted in: Investor updates, Press & Media

You can also register to watch the entire Zoom webcast on-demand by clicking here

Executive Chairman Bob Proulx on Pitt Street Research’s Stocks Down Under Podcast: Getting ready for a Phase 2 Study

August 21, 2025

Earlier this month, our own Bob Proulx, Executive Chairman of Imagion Biosystems, had the opportunity to join Stuart Roberts on Pitt Street Research’s podcast Stocks

Imagion Initiates Collaboration with Wayne State University to Develop Advanced Molecular Imaging Capabilities to Enable AI Cancer Diagnostics

August 13, 2025

Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilizing its proprietary MagSense® imaging

IBX Secures Firm Commitments for A$3.5M Capital Raising

August 4, 2025

Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer cells utilising its proprietary MagSense®

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

First in-human study update – webcast presentation

First in-human study update – webcast presentation

Related Articles

Executive Chairman Bob Proulx on Pitt Street Research’s Stocks Down Under Podcast: Getting ready for a Phase 2 Study

Imagion Initiates Collaboration with Wayne State University to Develop Advanced Molecular Imaging Capabilities to Enable AI Cancer Diagnostics

IBX Secures Firm Commitments for A$3.5M Capital Raising

Transforming medical imaging for early disease detection

About Imagion Biosystems

Contact us

Join our email list